Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer (Q87363127)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Peter P Truran

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sarah J Johnson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Richard D Bliss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Thomas W J Lennard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sebastian R Aspinall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

1 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

published in

World Journal of Surgery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

2845-2854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

Parafibromin tumor suppressor enhances cell growth in the cells expressing SV40 large T antigen

8 March 2020

cites work

1 reference

12 December 2020

Histological diagnosis of carcinoma of the parathyroid gland

1 reference

12 December 2020

Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma

1 reference

12 December 2020

Telomerase activation and expression of its catalytic subunits in benign and malignant tumors of the parathyroid.

1 reference

12 December 2020

Immunohistochemical Analysis of the Cell Cycle-Associated Antigens Ki-67 and Retinoblastoma Protein in Parathyroid Carcinomas and Adenomas

1 reference

12 December 2020

Parathyroid carcinoma: increasing incidence and changing presentation

1 reference

12 December 2020

FDG-PET/CT and parathyroid carcinoma: Review of literature and illustrative case series.

1 reference

12 December 2020

Diagnosis and management of parathyroid cancer.

1 reference

12 December 2020

Defining a molecular phenotype for benign and malignant parathyroid tumors

1 reference

12 December 2020

Clinical presentation, staging and long-term evolution of parathyroid cancer

1 reference

12 December 2020

High index of clinical suspicion with optimal surgical techniques and adjuvant radiotherapy is critical to reduce locoregional disease progression in parathyroid carcinoma

1 reference

12 December 2020

Natural history of parathyroid carcinoma. Diagnosis, treatment, and results

1 reference

12 December 2020

Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression

1 reference

12 December 2020

Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumours by in situ hybridization with a new oligonucleotide probe

1 reference

12 December 2020

Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias

1 reference

12 December 2020

Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study

1 reference

12 December 2020

Proposal for the histological classification of parathyroid carcinoma

1 reference

12 December 2020

Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

1 reference

12 December 2020

Diagnosis of parathyroid carcinoma using immunohistochemical staining against hTERT.

1 reference

12 December 2020

Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions

1 reference

12 December 2020

Parathyroid carcinoma: the Lahey Clinic experience

1 reference

12 December 2020

Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma

1 reference

12 December 2020

Intraoperative determination of PTH concentrations in fine needle tissue aspirates to identify parathyroid tissue during parathyroidectomy

1 reference

12 December 2020

Development of a formula to predict parathyroid carcinoma in patients with primary hyperparathyroidism

1 reference

12 December 2020

Immunohistochemistry in the era of personalised medicine

1 reference

12 December 2020

Changing clinicopathological practice in parathyroid disease

1 reference

12 December 2020

The immunolocalization of protein gene product 9.5 using rabbit polyclonal and mouse monoclonal antibodies.

1 reference

12 December 2020

Trends in the incidence and treatment of parathyroid cancer in the United States.

1 reference

12 December 2020

Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions

1 reference

12 December 2020

Parathyroid carcinoma: etiology, diagnosis, and treatment

1 reference

12 December 2020

Parathyroid carcinoma: a 43-year outcome and survival analysis

1 reference

12 December 2020

PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas

1 reference

12 December 2020

Parathyroid carcinoma: update and guidelines for management

1 reference

12 December 2020

Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma

1 reference

12 December 2020

Ultrasound features of malignancy in the preoperative diagnosis of parathyroid cancer: a retrospective analysis of parathyroid tumours larger than 15 mm.

1 reference

12 December 2020

Correlation between clinical and histological findings in parathyroid tumors suspicious for carcinoma

1 reference

12 December 2020

Needle tract sinus following aspiration biopsy of papillary thyroid carcinoma: a case report

1 reference

12 December 2020

Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma

1 reference

12 December 2020

Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors

1 reference

12 December 2020

Expression of parafibromin in major renal cell tumors

1 reference

12 December 2020

Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms

1 reference

12 December 2020

Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification

1 reference

12 December 2020

Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue

1 reference

12 December 2020

Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

1 reference

12 December 2020

The role of PGP9.5 as a tumor suppressor gene in human cancer

1 reference

12 December 2020

Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas

1 reference

12 December 2020

Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?

1 reference

12 December 2020

Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease

1 reference

12 December 2020

Parathyroid carcinoma: a difficult histological diagnosis

1 reference

12 December 2020

Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases

1 reference

12 December 2020

Implantation of parathyroid carcinoma along fine needle aspiration track

1 reference

12 December 2020

Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma

1 reference

12 December 2020

Lymph node involvement and surgical approach in parathyroid cancer.

1 reference

12 December 2020

Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma

1 reference

12 December 2020

Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining

1 reference

12 December 2020

Parathyroid cancer: outcome analysis of 16 patients treated at the Princess Margaret Hospital

1 reference

12 December 2020

Parathyroid carcinoma encountered after minimally invasive focused parathyroidectomy may not require further radical surgery.

1 reference

12 December 2020

Parafibromin expression in breast cancer: a novel marker for prognostication?

1 reference

12 December 2020

Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas

1 reference

12 December 2020

10.1007/S00268-014-2700-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002250%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference